Rapid molecular testing for clinical diagnostics

Abacus Diagnostica’s proprietary, fully automated testing platform GenomEra® CDX takes molecular testing to a new level of easiness and speed without compromising the quality of results.

Cost efficient automated solution

All-in-one PCR and RT-PCR test chips with homogeneous detection in fully automated instrument.

Reducing the costs by affordable pricing, robust assays and long service intervals.



CE IVD tests for infectious diseases

Critical human pathogens and antibiotic resistance markers such as C. difficile, Norovirus and MRSA

Our products

GenomEra CDX system has proven to be one of the fastest, easiest-to-use and the most cost-effective automated solution for molecular diagnostics (MDx) of infectious diseases. GenomEra is suitable also for small to mid-size customers without any prior experience in MDx.

See all products


  • Great FLU A/B + RSV results at ESCV 2019!

    ESCV conference is taking place in Copenhagen. Dr. Pichon from CHU Poitiers, France is presenting first and excellent results from GenomEra Flu A/B + RSV evaluations, which they did in last winter. Go to check poster P111. Should you wish to select GenomEra system for next influenza season, please contact info@abacusdiagnostica.com to order a demo.

  • New publication of the upcoming direct GenomEra GBS assay for intrapartum screening is available

    Results shows equal sensitivity to culture and article highlights the usability of GenomEra.

    From the conclusions: “GenomEra GBS PCR assay has potential as an easy and rapid on-site test for intrapartum detection of vaginal carriage of GBS at a maternity ward to identify women in labor who should receive intrapartum antibiotic prophylaxis.”


  • GenomEra Flu A/B + RSV CE IVD approved and available!

    Abacus Diagnostica´s GenomEra Flu A/B + RSV is now CE IVD approved and available! To discuss more about our new product, come and meet us at ECCMID 2019 in Amsterdam, booth 1.148!


    Analyte                                 PPA (i.e. sensitivity)                        NPA (i.e. specificity)        Accuracy

    Flu A (n=1256)                   97.1%                                                    99.4%                                    98.6%

    Flu B (n=1256)                   100%                                                     100%                                     100%

    RSV (n=701)                        98%                                                        99.8%                                    98.7%

    Overall accuracy:  99.3%